About 54% of adults who had taken a GLP-1 drug, including those with insurance, said the cost was difficult to afford, according to KFF poll results released this month
A search of the patient database comprising clinic visits between December 2017 and November 2023 revealed 16,827 patients with no history of NAION
At the Endocrine Societys 2025 meeting, researchers reported that after about 10% weight loss on a GLP-1 drug, the share of men with normal total and free testosterone rose from 53% to 77%, with no hormone therapy given
Healthcare providers should educate patients on the importance of rotating injection sites to help minimize injection site reactions and maintain tissue integrity over long-term treatment
Scalable Dosing Options : The wide range of strengths allows for a precise titration schedule, minimizing initial side effects while reaching maximum therapeutic efficacy